Ionis Pharma’s Steven Hughes Joins Organovo as Chief Medical Officer

Xconomy San Diego — 

Steven Hughes has joined Organovo (NASDAQ: ONVO) to serve as the San Diego company’s chief medical officer. Hughes comes to Organovo from Carlsbad, CA-based Ionis Pharmaceuticals (NASDAQ: IONS), where he was chief clinical development officer. His experience also includes senior leadership roles at Biogen (NASDAQ: BIIB), CSL Behring, and Sanofi (NYSE: SNY). Organovo has several preclinical programs being developed as treatments for liver conditions.